Ezinneka ​​​​ Imoh, PharmD ​​​​

Bio:

Ezinneka is a strategic Medical Communications leader with several years of US and global experience shaping scientific communications, publications strategy, and medical education across rare diseases, hematology, oncology, immunology, and cell and gene therapies. She is recognized as a trusted thought leader who translates complex clinical and real-world data into impactful, compliant, and patient-centered scientific narratives that inform healthcare decision-making and advance global medical strategy.
Currently, Ezinneka serves as the Global Lead for Scientific Communications and Medical Education in Rare Diseases at Chiesi, where she is accountable for end-to-end global scientific communications. Her scope includes publications strategy, scientific platform development, congress strategy and execution, multichannel HCP education, and field medical content across a diverse rare disease portfolio. She leads strategy and execution for global and regional congresses annually and plays a key role on therapeutic area core teams, shaping evidence dissemination across the product lifecycle. Ezinneka’s work has spanned early-stage pipeline assets through post-launch brands, with a consistent focus on scientific rigor, compliance, and alignment with evolving industry standards.
A proven people leader, Ezinneka is deeply committed to talent development and mentorship, including PharmD fellowship training and the advancement of best practices in medical communications. She is a frequently invited speaker and panelist at global industry conferences, where she is known for her perspectives on patient-centered engagement, plain language summaries, evidence generation and the role of scientific storytelling in building trust.
She holds a Doctor of Pharmacy (PharmD) from Fairleigh Dickinson University and a Bachelor of Science in Biology from the University of Texas at Arlington.